LIMITED STAGE SMALL CELL LUNG CANCER
Clinical trials for LIMITED STAGE SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LIMITED STAGE SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LIMITED STAGE SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop lung cancer relapse after Chemo-Radiation
Disease control OngoingThis phase 3 study tests whether tarlatamab, an experimental drug, can delay cancer progression or improve survival in people with limited-stage small-cell lung cancer who have finished chemoradiation without their cancer getting worse. About 404 participants will receive either …
Matched conditions: LIMITED STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New immunotherapy combo shows promise for tough lung cancer
Disease control OngoingThis phase 3 trial is testing whether adding the immunotherapy drug serplulimab to standard chemoradiotherapy helps people with limited-stage small cell lung cancer live longer and keep the cancer from growing. About 511 participants will receive either serplulimab or a placebo a…
Matched conditions: LIMITED STAGE SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC